M16-000
ClinicalTrials.gov NCT03105102
Research payments
$3,495,139
Through program year 2020, $3,495,139 in research payments was reported against M16-000, across 1,147 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03105102
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,283,729 | 768 |
| 2019 | Research | $1,211,410 | 379 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Harry Ojeas Houston, TX Named on 39 payments
- Sara Horst Nashville, TN Named on 31 payments
- Paul Hellstern Crystal River, FL Named on 31 payments
- Themistoe Dassopoulos Dallas, TX Named on 28 payments
- Henry Levine Orlando, FL Named on 28 payments
- Christopher Johnson Temple, TX Named on 27 payments
- Edward Loftus Rochester, MN Named on 27 payments
- Shahriar Sedghi Macon, GA Named on 25 payments
- Raymond Phillips Naples, FL Named on 24 payments
- Anita Afzali Columbus, OH Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.